Raymond, Britany L.
Allen, Brian F. S.
Freundlich, Robert E.
Parrish, Crystal G.
Jayaram, Jennifer E.
Wanderer, Jonathan P.
Rice, Todd W.
Lindsell, Christopher J.
Scharfman, Kevin H.
Dear, Mary L.
Gao, Yue
Hiser, William D.
McEvoy, Matthew D.
Bernard, Gordon R.
Dittus, Robert S.
Dwyer, Shon
EmbĂ, Peter J.
Fitzgerald, Chad
Gatto, Cheryl L.
Harrell, Frank E.
Harris, Paul A.
Hartert, Tina
Hayman, Jim
Ivory, Catherine H.
Kleinpell, Ruth
Kripalani, Sunil
Liska, Lee Ann
Luther, Patrick
Morrison, Jay
Nantais, Thomas
Pulley, Jill M.
Rehm, Kris
Rothman, Russell L.
Runyan, Patti
Self, Wesley H.
Semler, Matthew W.
Steaban, Robin
Stone, Cosby A. Jr
Walker, Philip D.
Wilkins, Consuelo H.
Wright, Adam
Zuckerman, Autumn D.
,
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR002243, UL1 TR002243, UL1 TR002243, UL1 TR002243, UL1 TR002243, UL1 TR002243, UL1 TR002243)
Article History
Received: 28 February 2023
Accepted: 12 June 2023
First Online: 30 June 2023
Declarations
:
: The IMPAKT ERAS trial has been approved by the institutional review board at Vanderbilt University Medical Center. All methods were carried out in accordance with relevant guidelines and regulations (Declarations of Helsinki). The board determined the study to be of minimal risk and approved a shortened, modified research consent process with a shortened form. Enrolled patients provide written informed consent to participate in the trial.
: Not applicable.
: MM serves on the scientific advisory board for Takeda Pharmaceuticals, and the role is unrelated to this work.RF owns stock in 3 M, and he serves as a consultant for Oak Hill Clinical Informatics and Phillips. He declares no conflicts of interest with this work.CL owns stock in Bioscape Digital, which is unrelated to this work.TR has relations with Cumberland Pharmaceuticals, Inc. (Director of Medical Affairs), Cytovale, Inc. (Consultant), and Sanofi, Inc. (Member of the Data Safety and Monitoring Board). No conflicts or relationships are related to this work. All other authors declare no competing interests.